The title compound, C(12)H(22)O(11)·2H(2)O {systematic name: 6,6'-oxybis[2-(hy-droxy-meth-yl)-3,4,5,6-tetra-hydro-2H-pyran-3,4,5-triol] dihydrate}, is a disaccharide, which was isolated from Tremella fuciformis. The mol-ecule contains two six-membered rings, both of which adopt a chair conformation. Extensive O-H⋯O hydrogen bonds occur in the crystal structure.

Ten members of the mezzettiaside family of natural products were synthesized and evaluated for anticancer and antibacterial activity. Complete anticancer (H460) and antibacterial (B. subtilis) activities for the ten natural products and four new analogues were found. Comparison to the cleistrioside and cleistetroside classes of natural products were made.

The title compound, C(13)H(24)O(11)·4H(2)O, forms extended hydrogen-bonded networks. These are present between disaccharides, but not as inter-residue hydrogen bonds, as well as to water mol-ecules that in addition form an inter-molecular chain of hydrogen bonds. The conformation of the disaccharide is described by the glycosidic torsion angles ϕ(H) = -34° and ψ(H) = -5°. Macroscopically, the d...

A two-step strategy for disaccharide modulation using vancomycin as a model is reported. The strategy relies upon a glycosyltransferase-catalyzed 'reverse' reaction to enable the facile attachment of an alkoxyamine-bearing sugar to the vancomycin core. Neoglycosylation of the corresponding aglycon led to a novel set of vancomycin 1,6-disaccharide variants. While the in vitro antibacterial prope...